Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Monsenso A/S, established in Copenhagen, Denmark in 2013, specializes in developing and marketing digital health solutions for the treatment of mental disorders. The company offers a multi-faceted platform, including a dedicated Monsenso app for individuals, which assists users with self-assessments, questionnaires, sensor data collection from personal devices, medication and session reminders, visual progress tracking, motivational feedback, and psychoeducation incorporating cognitive behavioral therapy. A separate application is available for caregivers, providing self-assessment tools, questionnaires, educational content, and various learning resources. For healthcare professionals, Monsenso provides a clinical web portal designed for visualizing patient data, managing patient dashboards, reviewing historical overviews, conducting correlation analysis, facilitating secure messaging, supporting shared decision-making, and maintaining medical records. Additionally, clinicians have access to data analytics features, enabling the aggregation of historical health and behavioral data, statistical descriptions, analysis of correlations between behavior and illness progression, pattern identification, predictive mood forecasting, and risk assessment. The company's innovative tools are utilized by patients, their caregivers, clinical staff, healthcare systems, and researchers.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers.